Skip to main content
Walter Urba, MD, Oncology, Portland, OR, Providence Portland Medical Center

WalterJohnUrbaMDPhD

Oncology Portland, OR

Hematologic Oncology, Melanoma

Director, Earle. A. Chiles Research Institute, Providence Cancer Center, Portland, Oregon

Dr. Urba is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Urba's full profile

Already have an account?

Summary

  • Dr. Walter Urba is an oncologist in Portland, OR and is affiliated with Providence Portland Medical Center. He received his Ph.D. in Immunology from UCLA and his medical degree from University of Miami Miller School of Medicine. He completed his medical oncology fellowship at the NCI. He specializes in medical oncology with expertise in immuno-oncology. He is director of the Robert W. Franz Cancer Center, Earle A. Chiles Research Institute and physician director of research for Providence in Oregon.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1983 - 1986
  • Atlantic Health System/Morristown Medical Center
    Atlantic Health System/Morristown Medical CenterResidency, Internal Medicine, 1981 - 1983
  • University of Miami Leonard M. Miller School of Medicine
    University of Miami Leonard M. Miller School of MedicineClass of 1981

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1982 - Present
  • OR State Medical License
    OR State Medical License 1993 - 2025
  • MD State Medical License
    MD State Medical License 1984 - 1993
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2003-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Portland Monthly Magazine Castle Connolly, 2011
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Society for Immunotherapy of Cancer Perspective on Regulation of Interleukin-6 Signaling in COVID-19-Related Systemic Inflammatory Response  
    Steven J O'Day, Walter J Urba, Jeffrey S Weber, Journal For Immunotherapy of Cancer

Press Mentions

  • Germinal Center Reactions in Tertiary Lymphoid Structures Associate with Neoantigen Burden, Humoral Immunity and Long-Term Survivorship in Pancreatic Cancer
    Germinal Center Reactions in Tertiary Lymphoid Structures Associate with Neoantigen Burden, Humoral Immunity and Long-Term Survivorship in Pancreatic CancerMarch 17th, 2021
  • Germinal Center Reactions in Tertiary Lymphoid Structures Associate with Neoantigen Burden, Humoral Immunity and Long-Term Survivorship in Pancreatic Cancer
    Germinal Center Reactions in Tertiary Lymphoid Structures Associate with Neoantigen Burden, Humoral Immunity and Long-Term Survivorship in Pancreatic CancerDecember 8th, 2020
  • Providence Researchers Developing Unique COVID-19 Vaccine
    Providence Researchers Developing Unique COVID-19 VaccineJuly 11th, 2020
  • Join now to see all

Grant Support

  • Clinical Trial Of Dribble Vaccine In NsclcNational Cancer Institute2008–2009
  • Peptide Booster Vaccination In A2+ Melanoma PatientsNational Cancer Institute2004–2005
  • GP100 Peptide Immunization After Lymphocyte DepletionNational Cancer Institute2003–2004
  • Immune Response To The Mutated Gp?00 Peptide (209o-2m)National Cancer Institute2000
  • Immune Response To The Mutated GP 100 Peptide (209o 2m)National Cancer Institute1999
  • Vaccination With B7-Transfected Breast Cancer CellsNational Cancer Institute1996–1997

Professional Memberships

Hospital Affiliations